These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 2501061

  • 1. Effects of enzyme induction therapy on glucose and drug metabolism in obese mice model of non-insulin dependent diabetes mellitus.
    Karvonen I, Stengård JH, Huupponen R, Stenbäck FG, Sotaniemi EA.
    Diabetes Res; 1989 Feb; 10(2):85-92. PubMed ID: 2501061
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hepatic mixed function oxidase system and enzymatic glucose metabolism in rats.
    Karvonen I, Stengård JH, Saarni HU, Stenbäck F, Sotaniemi EA.
    Diabetes Res; 1987 Apr; 4(4):195-200. PubMed ID: 3040322
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Regulation of pathways of glucose metabolism in the kidney. The activity of the pentose phosphate pathway, glycolytic route and the regulation of phosphofructokinase in the kidney of lean and genetically obese (ob/ob) mice; comparison with effects of diabetes.
    Sochor M, Kunjara S, McLean P.
    Horm Metab Res; 1988 Nov; 20(11):676-81. PubMed ID: 2975263
    [Abstract] [Full Text] [Related]

  • 8. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice.
    Choi MS, Jung UJ, Yeo J, Kim MJ, Lee MK.
    Diabetes Metab Res Rev; 2008 Nov; 24(1):74-81. PubMed ID: 17932873
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mononuclear leukocytes from obese patients with type II diabetes have reduced activity of hexokinase, 6-phosphofructokinase and glucose-6-phosphate dehydrogenase.
    Muggeo M, Moghetti P, Querena M, Cacciatori V, Zoppini G, Zenere M, Tosi F, Travia D, Bonora E.
    Horm Metab Res; 1993 Mar; 25(3):160-4. PubMed ID: 8477954
    [Abstract] [Full Text] [Related]

  • 11. An analysis of the relationships among obesity, plasma insulin and hepatic lipogenic enzymes in "viable yellow obese" mice (Avy/a).
    Yen TT, Greenberg MM, Yu PL, Pearson DV.
    Horm Metab Res; 1976 May; 8(3):159-66. PubMed ID: 7520
    [Abstract] [Full Text] [Related]

  • 12. The antihyperglycemic effect of estrone sulfate in genetically obese-diabetic (ob/ob) mice is associated with reduced hepatic glucose-6-phosphatase.
    Borthwick EB, Houston MP, Coughtrie MW, Burchell A.
    Horm Metab Res; 2001 Dec; 33(12):721-6. PubMed ID: 11753757
    [Abstract] [Full Text] [Related]

  • 13. Cold exposure and liver NADPH generating enzymes in genetically obese (ob/ob) mice.
    Karvonen I, Stengård JH, Saarni HU, Sotaniemi EA, Stenbäck F.
    Arctic Med Res; 1988 Dec; 47 Suppl 1():265-8. PubMed ID: 3272617
    [No Abstract] [Full Text] [Related]

  • 14. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice.
    Flatt PR, Bailey CJ, Hampton SM, Swanston-Flatt SK, Marks V.
    Horm Metab Res; 1987 Jan; 19(1):1-5. PubMed ID: 3549500
    [Abstract] [Full Text] [Related]

  • 15. Effects of doxylamine succinate on thyroid hormone balance and enzyme induction in mice.
    Bookstaff RC, Murphy VA, Skare JA, Minnema D, Sanzgiri U, Parkinson A.
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):584-94. PubMed ID: 8975784
    [Abstract] [Full Text] [Related]

  • 16. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE, Evans JS, Holmes D, Baker MT.
    Drug Nutr Interact; 1983 Dec; 2(2):117-30. PubMed ID: 6432511
    [Abstract] [Full Text] [Related]

  • 17. Circadian variations in the activities of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in the liver of control and streptozotocin-induced diabetic rats.
    Ulusu NN, Ozbey G, Tandogan B, Gunes A, Durakoglugil DB, Karasu C, Uluoglu C, Zengil H.
    Chronobiol Int; 2005 Dec; 22(4):667-77. PubMed ID: 16147898
    [Abstract] [Full Text] [Related]

  • 18. Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose.
    Agrawal AK, Shapiro BH.
    Mol Pharmacol; 1996 Mar; 49(3):523-31. PubMed ID: 8643092
    [Abstract] [Full Text] [Related]

  • 19. Glucose-6-phosphate dehydrogenase activity and NADPH/NADP+ ratio in liver and pancreas are dependent on the severity of hyperglycemia in rat.
    Díaz-Flores M, Ibáñez-Hernández MA, Galván RE, Gutiérrez M, Durán-Reyes G, Medina-Navarro R, Pascoe-Lira D, Ortega-Camarillo C, Vilar-Rojas C, Cruz M, Baiza-Gutman LA.
    Life Sci; 2006 Apr 25; 78(22):2601-7. PubMed ID: 16325866
    [Abstract] [Full Text] [Related]

  • 20. Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats.
    Enriquez A, Leclercq I, Farrell GC, Robertson G.
    Biochem Biophys Res Commun; 1999 Feb 16; 255(2):300-6. PubMed ID: 10049703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.